On Aug. 25, Medicare will begin to implement its new national coverage decision (NCD) that expands coverage of prothrombin time monitoring for home anticoagulation management to encompass more beneficiaries on warfarin therapy.
Subscribers: click here for the full storyNon-Subscribers: click here to subscribe
Archives